Our results showed that deletion of TCAF2 in TPCs suppressed CRC metastasis, as indicated by the decreased number of circulating tumor cells (CTCs) (Figure S15C, Supporting Information), and liver metastases (Figure 3B). Here, TCAF2 is linked to neoplasm.